Proteomics, biotechnology, and life sciences innovation by Nautilus
Nautilus Biotechnology invites project proposals for Tau Proteoforms Assay grant program
Nautilus Biotechnology has launched its Iterative Mapping Grant Program, inviting researchers to submit project proposals by July 31st, 2026. Selected projects will have the opportunity to ...
Nautilus Biotechnology to present single molecule proteomics webinar on Voyager Platform
Nautilus Biotechnology will host a webinar tomorrow at 8am PT focusing on achieving mechanistic clarity through accessible single-molecule proteomic analysis on its Voyager Platform. Presenters ...
Nautilus Biotechnology event to reveal new Iterative Mapping method for scientific clarity
Nautilus Biotechnology is set to host a webinar this Thursday, July 9th at 8am PT, led by Sheri Wilcox, Ph.D., Vice President of Scientific Engagement, and Amber (Kessinger) Faust, Vice President ...
Nautilus Biotechnology launches eBook on proteomics driving Alzheimer research progress
Nautilus Biotechnology has published the latest edition of its "Proteomics and neuroscience" eBook, showcasing how its Voyager Platform is being applied to advance research on tau proteoforms in ...
Tau proteoform quantification research unveiled by Nautilus Biotechnology at ASMS2026
Nautilus Biotechnology announced that its Senior Director of Scientific Affairs and Alliance Management, Andreas Huhmer, will deliver a poster presentation (#644) at ASMS2026, focusing on ...
Nautilus Biotechnology promotes single molecule proteomics at ASMS with Voyager platform experts
Nautilus Biotechnology is actively presenting its single molecule proteomics enabled by Iterative Mapping on the Nautilus Voyager Platform to attendees at the ASMS conference. Key team members, ...
Nautilus Biotechnology introduces Voyager Platform for precise tau proteoform analysis
Nautilus Biotechnology leverages the Tau Global 2026 conference to spotlight its Voyager Platform, which enables measurement of tau proteoforms with single-molecule accuracy, sensitivity, and ...
Nautilus Biotechnology unveils Voyager Platform for quantifying 768 tau proteoforms at Tau Global 2026
Nautilus Biotechnology is set to showcase its Voyager Platform at Tau Global 2026 in Washington D.C. this Thursday and Friday, May 14 and 15th. Attendees are invited to learn how the company uses ...
Nautilus Biotechnology launches recruitment drive for Iterative Mapping Early Access Program
Nautilus Biotechnology is intensifying its presence at conferences, roadshows, and related industry events to attract innovative scientists. The company is promoting the adoption of its Nautilus ...
Nautilus Biotechnology CEO joins Biocom panel on AI impact in biotech sector
Nautilus Biotechnology’s Co-Founder and CEO Sujal Patel will participate in a panel at the Biocom Converge Summit this Thursday, April 23, at 11:40am PT. The discussion will examine the ...
Nautilus Biotechnology details how artificial intelligence transforms proteomics insights
Nautilus Biotechnology delves into how statistics and artificial intelligence are reshaping the field of proteomics, according to the latest company blog post summarizing a recent Translating ...
Nautilus Biotechnology accelerates with Voyager Platform launch and first customer announcements
Nautilus Biotechnology has rolled out the Nautilus Voyager Platform, a major step for the company in recent months. In addition to the platform launch, Nautilus Biotechnology has initiated its ...
Baylor College of Medicine initiates research with Nautilus Biotechnology Voyager Platform
Nautilus Biotechnology has announced Baylor College of Medicine as the inaugural customer for its Iterative Mapping Early Access Program. Under a research initiative led by professors Bing Zhang, ...
Nautilus Biotechnology names Amber Faust as Vice President of Sales to drive proteomics expansion
Nautilus Biotechnology has appointed Amber Faust as Vice President of Sales to strengthen its commercial operations in the proteomics sector. Faust brings a proven track record of leading sales ...
Nautilus Biotechnology unveils proteomics episode with US HUPO President-Elect Olga Vitek
Nautilus Biotechnology introduces the latest episode of its Translating Proteomics series, highlighting an in-depth conversation between Professor Olga Vitek Ph.D., President-Elect of US HUPO and ...
Nautilus Biotechnology explores multiomics to mitigate space travel effects
Nautilus Biotechnology delves into the effects of space travel on the human body and seeks to mitigate these impacts through multiomics. In a recent discussion, Parag Mallick from Nautilus ...
Nautilus Biotechnology launches Iterative Mapping Early Access Program
Nautilus Biotechnology has announced the launch of its Iterative Mapping Early Access Program, aimed at advancing research and development efforts. The program offers participants an opportunity ...
Nautilus Biotechnology drives innovation in proteomics space
Nautilus Biotechnology is at the forefront of innovation in the proteomics space, driven by growing adoption in population studies and recognition of proteoforms' potential. The company’s ...
Nautilus Biotechnology redefines proteomics at HUPO2025
Nautilus Biotechnology is bringing groundbreaking innovations to the field of proteomics with their presence at HUPO2025. The company is set to showcase their Iterative Mapping technology, a ...
Nautilus Biotechnology aims to revolutionize biomedicine with proteome platform
Sujal Patel, Co-Founder and CEO of Nautilus Biotechnology, recently sat down with Nasdaq's Amplify Spotlight series to discuss the company's innovative approach to biomedicine. During the ...
